As of the latest trading close, GOSS, a Healthcare sector stock, is trading -44.61% below its 52-week high but remains 89.62% above its 52-week low. The Average True Range (ATR) (14 days) of 0.06 ...

Gossamer Bio (GOSS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 11. Analyst Joseph Schwartz from Leerink Partners reiterated a Buy rating on ...

Bruton Knowles, the independent national chartered surveyor firm, has announced the acquisition of Haarer Goss, a ...

In a report released today, Andreas Argyrides from Oppenheimer maintained a Buy rating on Gossamer Bio (GOSS – Research Report), with a price target of $9.00. The company’s shares closed yesterday at ...

Goss, who is expected to join a Formula 1 team ... with three decades of experience in sporting management - left because he believed the FIA was not willing to make the changes he felt were ...

Exeter-based commercial property management firm Haarer Goss has been bought by Bruton Knowles an independent national ...

Gossamer Bio, Inc. ( NASDAQ:GOSS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's statutory forecasts. The consensus estimated revenue ...

Bruton Knowles, the independent national chartered surveyor firm, has announced the acquisition of Haarer Goss, a well-established commercial property management firm based in Exeter. This strategic ...

Christopher Ayer, a former senior vice president at Pallas Capital Advisors, will bring his expertise working with ...

Gossamer Bio (GOSS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.21 per share a year ago. These figures are ...

Plans are about priorities and how we choose to make use of our limited time and energy. "Oftentimes, having to cancel plans isn't so much about etiquette as it is about time management," says Jan ...